… the drug, company and its clinical trials play a fundamental role in … , prostate cancer, and small-cell lung cancer. It is administered through the …

… the drug, company and its clinical trials play a fundamental role in … leukemia (ALL), advanced biliary cancer, lung cancer, second-line patients with chronic … cell lymphoma, non-small cell lung cancer and chronic myeloid leukemia. While …

… the drug, company and its clinical trials play a fundamental role in … including non-small cell lung cancer, small-cell lung cancer metastatic melanoma, head and …

… advanced nonsquamous non-small cell lung cancer (NSCLC). Dato-DXd is intended … the Phase III TROPION-Lung01 clinical trial. This global, multicentre trial assessed …

… Oncology is currently conducting clinical trials with avutometinib with and … mutant non-small cell lung cancer progressed on a G12C … Phase 1b/2 clinical trial evaluating avutometinib and defactinib … ; that enrollment of clinical trials may take longer than …

… , was found in a large clinical trial to be even more effective … , used in non-small cell lung cancer that tests positive for a …

… the drug, company and its clinical trials play a fundamental role in … , HER2 expressing non-small cell lung cancer, non-muscle invasive bladder cancer …

… the drug, company and its clinical trials play a fundamental role in … , colon cancer, gallbladder cancer and lung cancer. The drug candidate is an …

… the drug, company and its clinical trials play a fundamental role in … treatment of non-small cell lung cancer, advanced breast cancer, advanced liver …

… the drug, company and its clinical trials play a fundamental role in … leukemia, solid tumors,  small-cell lung cancer. The drug candidate is formulated …